Compound information
- Natural Products
- ZC469331
- Molecular Formula
- C14H22N4O3
- Molecular Weight
- 294.169190564 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(pyrazole-1-carbonyl)-1,4-diazepane-1-carboxylate
- InChI
- InChI=1S/C14H22N4O3/c1-14(2,3)21-13(20)17-8-5-7-16(10-11-17)12(19)18-9-4-6-15-18/h4,6,9H,5,7-8,10-11H2,1-3H3
- InChI Key
- SREDUUSCWDQNQK-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCCN(C(=O)n2cccn2)CC1
- Source
- ZINC000299834914
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 0 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 67.67 Å2 | LogP | 1.737 |
LogS | -1.449 | LogD | 1.675 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.337 | Pgp substrate | 0.028 |
HIA | 0.963 | F20 % | 0.033 |
F30 % | 0.458 | Caco-2 | -4.369 |
MDCK | -4.805 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.844 | PPB | 49.716 |
VD | 1.012 | Fu | 0.413 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.521 |
CYP2A6 substrate | 0.696 | CYP2B6 substrate | 0.618 |
CYP2C19 inhibitor | 0.397 | CYP2C19 substrate | 0.733 |
CYP2C8 substrate | 0.507 | CYP2C9 inhibitor | 0.015 |
CYP2C9 substrate | 0.96 | CYP2D6 inhibitor | 0.061 |
CYP2D6 substrate | 0.894 | CYP2E1 substrate | 0.898 |
CYP3A4 inhibitor | 0.005 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.863 | CL | 5.208 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.048 | Hepatotoxicity | 0.976 |
Mutagenicity | 0.077 | Rat Oral Acute Toxicity | 0.659 |
FDAMDD | 0.077 | Skin Sensitization | 0.01 |
Carcinogenicity | 0.935 | Eye Corrosion | 0.003 |
Eye Irritation | 0.085 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.589 | IGC50 | 1.757 |
LC50FM | 2.043 | LC50DM | 1.271 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.402 | NR-AR-LBD | 0.226 |
NR-AhR | 0.087 | NR-Aromatase | 0.028 |
NR-ER | 0.22 | NR-ER-LBD | 0.37 |
NR-PPAR-gamma | 0.124 | SR-ARE | 0.593 |
SR-ATAD5 | 0.268 | SR-HSE | 0.199 |
SR-MMP | 0.009 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.